GPT and metabolic dysfunction-associated steatotic liver disease: The biochemical test results showed that compared with the Antagomir-NC-treated cells, the Antagomir-103-3p-treated NAFLD group cells had significantly decreased TG, ALT, and AST contents (Fig. 2A).